Author | Melinda Harper, RN

Articles

Irinotecan in the Management of Patients With Pancreatic Cancer

December 03, 2000

Synergy with no overlapping toxicities has been demonstrated for the combination of irinotecan ( Camptosar, CPT-11) and gemcitabine (Gemzar) in vitro. Results of a single-institution phase I study in which patients with